New

Brain Cancer Diagnostics Market

2021

Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, and Others), Cancer Type (Astrocytoma, Glioblastoma Multiforme, Ependymomas, and Others), and End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others); and Geography

Publication Month: Sep 2021 | Report Code: TIPRE00024461 | No. of Pages: 193 | Category: Medical Device | Status: Published

Market Insights

Brain Cancer Diagnostics Market to Grow at a CAGR of 16.6% to reach US$ 2,476.14 Million from 2020 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The brain cancer diagnostics market was valued at US$ 844.63 million in 2021 and is projected to reach US$ 2,476.14 million by 2028; it is expected to grow at a CAGR of 16.6% from 2021 to 2028.

Brain cancer is caused due to extracellular growth of the cells in the brain that causes tumors. Tumors can be primary brain tumors and secondary brain tumors. Primary brain tumors are formed in the brain and do not spread to other body parts, whereas secondary tumors, also known as metastases, are those cancers that began in another part of the body. Symptoms of brain cancer include headaches, nausea, fatigue, drowsiness, and many more.

The scope of the brain cancer diagnostics market includes diagnostic type, cancer type, end user, and region. The brain cancer diagnostics market is analyzed based on regions such as North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the brain cancer diagnostics market, emphasizing various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world.

Lucrative Regions for Brain Cancer Diagnostics Market

Lucrative Regions for Brain Cancer Diagnostics Market

Get more information on this report :


Market Insights

Increase in Prevalence of Brain Cancer Worldwide


Cancer of the brain and nervous system is the tenth highest cause of mortality in men and women. According to the American Society of Clinical Oncology (ASCO), in 2021, around 24,530 adults (13,840 men and 10,690 women) are likely to be diagnosed with primary cancerous tumors of the brain and spinal cord in the US. In a person's lifetime, the chances of having this form of tumor are lesser than 1%. Most primary central nervous system (CNS) malignancies are brain tumors, which account for 85% to 90% of all cases. Brain tumors can be fatal, have a severe impact on the quality of life, and ultimately turn a patient's and their family's lives.

Similarly, Cancer Research UK estimated that around 12,100 new cases of brain, other CNS, and intracranial tumors are diagnosed in the UK each year, which makes it around 33 cases per day (2015–2017). Brain tumors and other central nervous systems and intracranial tumors are the ninth most common malignancies in the UK, accounting for 3% of all new cancer cases (2017). Also, it is the eighth most common cancer in females in the UK with around 6,100 new cases in 2017. In males in the UK, brain, other CNS, and intracranial tumors are the eleventh most common cancer, with about 5,800 new cases in 2017. Incidence rates for brain tumors are projected to rise by 6% in the UK between 2014 and 2035, to 22 cases per 100,000 people by 2035.

Diagnostic Type-Based Insights

Based on diagnostic type, the brain cancer diagnostics market is segmented into imaging test, lumbar puncture, biopsy, molecular testing, and others. The imaging test segment held the largest share of the market in 2021, and the molecular testing segment is anticipated to register the highest CAGR in the market during the forecast period. The imaging test segment is further classified into magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET).

Global Brain Cancer Diagnostics Market, by Diagnostic Type – 2021 & 2028

Global Brain Cancer Diagnostics Market, by Diagnostic Type – 2021 & 2028

Get more information on this report :


Cancer Type-Based Insights

Based on cancer type, the brain cancer diagnostics market is segmented into Astrocytomas, Glioblastoma Multiforme, Ependymomas, and others. The Glioblastoma Multiforme segment held the largest share of the market in 2021, and the same segment is estimated to register the highest CAGR in the market during the forecast period. Growth of the Glioblastoma Multiforme segment is attributed to the increased prevalence of this type of brain cancer.


Report Coverage

End User–Based Insights

Based on end user, the brain cancer diagnostics market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2021. The specialty clinics segment is estimated to register the highest CAGR in the market during the forecast period.

The COVID-19 pandemic has become the most significant challenge across the world. It has disturbed various trades and businesses across the world. As a result of the COVID-19 pandemic, many diagnostic departments have experienced a rapid decline in imaging case volumes. This has important implications on the short-term and long-term economic stability of neurological procedures across all healthcare practice settings. Due to lockdowns imposed by governments across the world, many neurological procedures were delayed, and supply chain restrictions limited the availability of resources needed to deliver brain cancer diagnostic services.

Acquisition, collaboration, partnerships, new product launches, and expansion strategies are commonly adopted by companies to expand their footprint worldwide and meet the growing demand.

The market players operating in the brain cancer diagnostics market have adopted the strategy of product innovation to cater to the changing customer demand across the world, which also helps players to maintain their brand name globally.

Company Profiles

  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • GE Healthcare
  • MDxHealth
  • NantOmics
  • Biocept, Inc.
  • Koninklijke Philips N.V.
  • Canon Medical Systems
  • Hitachi, Ltd.
  • Neusoft Medical Systems

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2 Global Brain Cancer Diagnostics Market – By Cancer Type

1.3.3 Global Brain Cancer Diagnostics Market – By End User

1.3.4 Global Brain Cancer Diagnostics Market – By Geography

2. Global Brain Cancer Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Brain Cancer Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe– PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East and Africa – PEST Analysis

4.2.5 South and Central America (SCAM) – PEST Analysis

4.3 Experts Opinion

5. Brain Cancer Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Brain Cancer Worldwide

5.1.2 Rise in Number of Cigarette Smokers

5.2 Market Restraints

5.2.1 High Cost of Diagnosis

5.3 Market Opportunities

5.3.1 Increasing Opportunities in Emerging Economies

5.4 Future Trends

5.4.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.5 Impact Analysis

6. Brain Cancer Diagnostics Market – Global Analysis

6.1 Global Brain Cancer Diagnostics Market Revenue Forecast and Analysis

6.2 Global Brain Cancer Diagnostics Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Brain Cancer Diagnostics Market Analysis – By Diagnostic Type

7.1 Overview

7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2021 and 2028)

7.3 Imaging Tests

7.3.1 Overview

7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 MRI

7.3.3.1 Overview

7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 CT Scan

7.3.4.1 Overview

7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Positron emission tomography (PET)

7.3.5.1 Overview

7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Lumbar Puncture

7.4.1 Overview

7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Biopsy

7.5.1 Overview

7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Molecular Testing

7.6.1 Overview

7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. Brain Cancer Diagnostics Market Analysis – By Cancer Type

8.1 Overview

8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2021 and 2028)

8.3 Astrocytomas

8.3.1 Overview

8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Glioblastoma Multiforme

8.4.1 Overview

8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Ependymomas

8.5.1 Overview

8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Brain Cancer Diagnostics Market Analysis – By End User

9.1 Overview

9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Specialty Clinics

9.4.1 Overview

9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Global Brain Cancer Diagnostics Market – Geographic Analysis

10.1 North America: Brain Cancer Diagnostics Market

10.1.1 Overview

10.1.2 North America: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.3 North America Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.3.1 North America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.4 North America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.5 North America Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.6 North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.7 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.7.1 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.7.2 US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.7.2.1 US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.7.3 US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.7.4 US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.8 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.1 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.2 Canada Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.8.2.1 Canada Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.8.3 Canada Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.8.4 Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.9 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.9.1 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.9.2 Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.9.2.1 Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.9.3 Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.9.4 Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2 Europe: Brain Cancer Diagnostics Market Revenue and Forecasts to 2028

10.2.1 Europe: Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.2 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.2.2.1 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.2.3 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.2.4 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.2.5 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

10.2.6 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.6.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.6.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.2.6.2.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.2.6.3 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.2.6.4 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.2.7 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.7.1 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.7.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.2.7.2.1 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.2.7.3 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.2.7.4 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.2.8 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.8.1 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.8.2 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.2.8.2.1 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.2.8.3 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.2.8.4 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.2.9 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.9.1 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.9.2 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.2.9.2.1 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.2.9.3 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.2.9.4 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.2.10 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.10.1 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.10.2 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.2.10.2.1 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.2.10.3 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.2.10.4 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.2.11 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.11.1 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.2.11.2 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.2.11.2.1 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.2.11.3 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.2.11.4 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.3 Asia Pacific: Brain Cancer Diagnostics Market

10.3.1 Overview

10.3.2 Asia Pacific: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.3.3 Asia Pacific: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.3.3.1 Asia Pacific: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

10.3.4 Asia Pacific: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.3.5 Asia Pacific: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

10.3.6 Asia Pacific: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.3.7 China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.7.1 China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.7.2 China: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.3.7.2.1 China: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

10.3.7.3 China: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.3.7.4 China: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

10.3.8 Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.8.1 Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.8.2 Japan: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.3.8.2.1 Japan: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

10.3.8.3 Japan: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.3.8.4 Japan: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

10.3.9 India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.9.1 India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.9.2 India: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.3.9.2.1 India: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

10.3.9.3 India: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.3.9.4 India: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

10.3.10 Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.10.1 Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.10.2 Australia: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.3.10.2.1 Australia: Brain Cancer Diagnostics Market, By Imaging Tests, 2019–2028 (USD Million)

10.3.10.3 Australia: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.3.10.4 Australia: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

10.3.11 South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.11.1 South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.11.2 South Korea: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.3.11.2.1 South Korea: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

10.3.11.3 South Korea: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.3.11.4 South Korea: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

10.3.12 Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.12.1 Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.12.2 Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.3.12.2.1 Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

10.3.12.3 Rest of Asia Pacific: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.3.12.4 Rest of Asia Pacific: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

10.4 Middle East and Africa: Brain Cancer Diagnostics Market

10.4.1 Overview

10.4.2 Middle East & Africa: Brain Cancer Diagnostics Market- Revenue and Forecast to 2028 (US$ Million)

10.4.3 Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.4.3.1 Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)

10.4.4 Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.4.5 Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.4.6 Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.4.6.1 Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.1 Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.2 Saudi Arabia Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.4.6.1.2.1 Saudi Arabia Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)

10.4.6.1.3 Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.4.6.1.4 Saudi Arabia Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.4.6.2 UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.1 UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.2 UAE Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.4.6.2.2.1 UAE Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)

10.4.6.2.3 UAE Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.4.6.2.4 UAE Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.4.6.3 South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.1 South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.2 South Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.4.6.3.2.1 South Africa Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)

10.4.6.3.3 South Africa Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.4.6.3.4 South Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.4.6.4 Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.4.6.4.1 Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.4.6.4.2 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.4.6.4.2.1 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.4.6.4.3 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.4.6.4.4 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.5 South and Central America: Brain Cancer Diagnostics Market

10.5.1 Overview

10.5.2 South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.5.3 South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

10.5.3.1 South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.5.4 South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.5.5 South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.5.6 South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.5.6.1 Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.5.6.2 Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.5.6.2.1 Brazil Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.5.6.2.1.1 Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.5.6.2.2 Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.5.6.2.3 Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.5.6.3 Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.5.6.3.1 Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.5.6.3.2 Argentina Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.5.6.3.2.1 Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.5.6.3.3 Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.5.6.3.4 Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.5.6.4 Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.5.6.4.1 Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.5.6.4.2 Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.5.6.4.3 Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.5.6.4.4 Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.5.6.4.5 Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic on Brain Cancer Diagnostics Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Brain Cancer Diagnostics Market–Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Brain Cancer Diagnostics Market (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Siemens Healthineers AG

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GE Healthcare

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 MDxHealth

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 NantOmics

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Biocept, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Koninklijke Philips N.V.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Canon Medical Systems

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Hitachi, Ltd.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Neusoft Medical Systems

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 2. North America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 3. North America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 4. North America Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 6. US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 7. US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 8. US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Canada Brain Cancer Diagnostics Market, by Diagnostic Type - Revenue and Forecast to 2028 (USD Million)

Table 10. Canada Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)

Table 11. Canada Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)

Table 12. Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 14. Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 15. Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 16. Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn).

Table 18. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn).

Table 19. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 20. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 21. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type US$ Mn)

Table 22. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test US$ Mn)

Table 23. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 24. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 25. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 26. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 27. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 28. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 29. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 30. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 31. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 32. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 33. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 34. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 35. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 36. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 37. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 38. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 39. Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by Cancer Type (USD Million)

Table 40. Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by End User (USD Million)

Table 41. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 42. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 43. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 44. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 45. Asia Pacific: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 46. Asia Pacific: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 47. Asia Pacific Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 48. Asia Pacific Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 49. China: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 50. China: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 51. China: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 52. China: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 53. Japan: Brain Cancer Diagnostics Market, By Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

Table 54. Japan: Brain Cancer Diagnostics Market, By Imaging Test– Revenue and Forecast to 2028 (USD Million)

Table 55. Japan: Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 56. Japan: Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 57. India: Brain Cancer Diagnostics Market, By Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

Table 58. India: Brain Cancer Diagnostics Market, By Imaging Test– Revenue and Forecast to 2028 (USD Million)

Table 59. India: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 60. India: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 61. Australia: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 62. Australia: Brain Cancer Diagnostics Market, By Imaging Tests – Revenue and Forecast to 2028 (USD Million)

Table 63. Australia: Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 64. Australia: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 65. South Korea: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 66. South Korea: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 67. South Korea: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 68. South Korea: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 69. Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 70. Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 71. Rest of Asia Pacific: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 72. Rest of Asia Pacific: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 73. Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 74. Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 75. Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 76. Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 77. Saudi Arabia Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 78. Saudi Arabia Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 79. Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 80. Saudi Arabia Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 81. UAE Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 82. UAE Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 83. UAE Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 84. UAE Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 85. South Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 86. South Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 87. South Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 88. South Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 89. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 90. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 91. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 92. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 93. South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 94. South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 95. South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 96. South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 97. Brazil Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 98. Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 99. Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 100. Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 101. Argentina Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 102. Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 103. Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 104. Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 105. Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 106. Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 107. Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 108. Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 109. Organic Developments in the Brain Cancer Diagnostics Market

Table 110. Inorganic Developments in the Brain Cancer Diagnostics Market

Table 111. Glossary of Terms, Brain Cancer Diagnostics Market

LIST OF FIGURES

Figure 1. Brain Cancer Diagnostics Market Segmentation

Figure 2. Brain Cancer Diagnostics Market Segmentation, By Region

Figure 3. Global Brain Cancer Diagnostics Market Overview

Figure 4. Imaging Test Segment Held the Largest Share of the Product Segment in Brain Cancer Diagnostics Market

Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

Figure 6. Brain Cancer Diagnostics Market, by Geography (US$ Million)

Figure 7. Global Brain Cancer Diagnostics Market – Leading Country Markets (US$ Million)

Figure 8. Global Brain Cancer Diagnostics Market, Industry Landscape

Figure 9. North America PEST Analysis

Figure 10. Europe and PEST Analysis

Figure 11. Asia Pacific PEST Analysis

Figure 12. Middle East and Africa PEST Analysis

Figure 13. South and Central America (SCAM) PEST Analysis

Figure 14. Global Brain Cancer Diagnostics Market – Revenue Forecast and Analysis – 2020- 2028

Figure 15. Global Brain Cancer Diagnostics Market – By Geography Forecast and Analysis – 2021- 2028

Figure 16. Market Positioning of Key Players in Global Brain Cancer Diagnostics Market

Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2021 and 2028)

Figure 18. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2021 and 2028)

Figure 27. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Brain Cancer Diagnostics Market Revenue Share, by End User (2021 and 2028)

Figure 32. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. North America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 37. North America Brain Cancer Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 38. North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 39. US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 41. Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 42. Europe: Brain Cancer Diagnostics Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 43. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 44. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

Figure 45. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. Germany Brain Cancer Diagnostics Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 49. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 50. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 51. Asia Pacific: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 52. Asia Pacific Brain Cancer Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 53. Asia Pacific: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 54. China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 55. Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 56. India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 57. Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 58. South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 59. Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 60. Middle East and Africa: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 61. Middle East & Africa Brain Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 62. Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 63. Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 64. UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 65. South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 66. Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 67. South and Central America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 68. South and Central America Brain Cancer Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 69. South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 70. Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 71. Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 72. Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 73. Impact of COVID-19 Pandemic in North American Country Markets

Figure 74. Impact of COVID-19 Pandemic on Brain Cancer Diagnostics Market in Asia Pacific Countries

Figure 75. Impact of COVID-19 Pandemic on Brain cancer diagnostics Market in Asia Pacific Countries

Figure 76. Impact of COVID-19 Pandemic on Brain cancer diagnostics Market in Middle East and African Countries

Figure 77. Impact of COVID-19 Pandemic on Brain cancer diagnostics Market in South and Central American Countries

Figure 78. Growth Strategies in the Brain Cancer Diagnostics Market (%)

The List of Companies - Brain Cancer Diagnostics Market

  1. Thermo Fisher Scientific Inc.
  2. Siemens Healthineers AG
  3. GE Healthcare
  4. MDxHealth
  5. NantOmics
  6. Biocept, Inc.
  7. Koninklijke Philips N.V.
  8. Canon Medical Systems
  9. Hitachi, Ltd.
  10. Neusoft Medical Systems
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Brain Cancer Diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Brain Cancer Diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00024461
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

The brain cancers are caused due to extracellular growth of the cells in the brain that causes tumors. The tumor includes primary brain tumors and secondary brain tumors. Primary brain tumors are formed in the brain and do not spread to other body parts, whereas secondary tumors, also known as metastases, are those cancers that began in another part of the body. Symptoms of brain cancer include headaches, nausea, fatigue, drowsiness, and many more.

The factors that are driving growth of the market are increase in prevalence of brain cancer worldwide and technological advancement in diagnostics to support adoption of brain cancer diagnostics are expected to boost the growth of the global brain cancer diagnostics market.

The factors that are restraining the adoption of brain cancer diagnostics are high cost involved in brain cancer diagnostics.

The Brain Cancer Diagnostics market majorly consists of the players such as players Thermo Fisher Scientific Inc., Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems, Hitachi, Ltd., Neusoft Medical Systems and among others.

The market players are involved in acquisitions, strategic collaborations, and new product launches to withstand the competition. For instance, in April 2021, Siemens Healthineers AG has completed the acquisition of Varian Medical Systems, Inc. The combined company creates a unique, highly integrated portfolio for imaging, laboratory diagnostics, and cancer treatment, as well as has significant potential to increase value creation.

North America dominated the Brain Cancer Diagnostics market with a share of 35% in 2020. This is attributable to increasing focus of market players in the US and Canada, technological advancements in brain cancer diagnostics, rising in R&D activities for better diagnosis.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.